15 MAY 2020

Notice of Interim Results

UDG Healthcare plc (LSE: UDG), a leading international healthcare services provider, will be announcing its interim results for the six months to 31 March 2020 on the morning of Tuesday 19 May 2020.

In line with current government guidance on social distancing, the company has decided not to proceed with a physical results presentation. In place of this, Brendan McAtamney, Chief Executive Officer, and Nigel Clerkin, Chief Financial Officer, will host a presentation for analysts and investors via conference call and audio webcast, to discuss the company's half year results and provide an update on each of the Group's divisions.

It is suggested participants dial-in at least 15 minutes prior in order to ensure a timely start to the briefing.

 

Date: Tuesday 19 May 2020

Time: Presentation commencing at 8:30am. Please dial in at 8.15am.

Conference call registration link: https://secure.emincote.com/client/udghealthcare/udg003/vip_connect

Please note that questions will only be taken from the conference call

Webcast registration link: https://secure.emincote.com/client/udghealthcare/udg003

To view the slides alongside the conference call audio, please dial in to the conference call, and then follow the link to the webcast. Once registered and on the main webcast page, click "Slides Only for Conference Call" underneath Alternative Stream.

 

For further information, please contact:

UDG Healthcare plc
Keith Byrne

Head of Investor Relations, Strategy & Corporate Communications
Tel: + 353 (0) 1 468 9000

Powerscourt
Lisa Kavanagh / Jack Hickey / Eavan Gannon / Ella Morris
udghealthcare@powerscourt-group.com

 

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 8,500 people with operations in 26 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across two divisions: Ashfield and Sharp.

Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of the-art facilities in the US and Europe.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250. For more information, please go to: www.udghealthcare.com